1 Academic Urology Unit, University of Aberdeen, Aberdeen, UK. [email protected].
2 Erasmus MC, Rotterdam, Netherlands.
3 Guidelines Office, European Association of Urology, Arnhem, Netherlands.
4 Astellas, Leiden, The Netherlands.
5 Imperial College London, London, UK.
6 IQVIA, London, UK.
7 Bayer AG, Berlin, Germany.
8 Association EISBM, Vourles, France.
9 Translational Oncology and Urology Research, King's College London, London, UK.
10 European Alliance for Personalised Medicine (EAPM), Brussels, Belgium.
11 Department of Translational Medicine, Lund University, Lund, Sweden.
12 Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
13 The Hyve, Utrecht, Netherlands.
14 Sanofi, Chilly-Mazarin, France.
15 Pinsent Masons, Leeds, UK.
16 Tampere University (TAU), Tampere, Finland.
17 SAS, Tervuren, Belgium.
18 Weizmann Institute, Rehovot, Israel.
19 The Swedish Institute for Health Economics (IHE), Stockholm, Sweden.
20 Academic Urology Unit, University of Aberdeen, Aberdeen, UK.